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Abstract Aims/hypothesis: The aim of this study was to
assess the predictive role of autonomic reactivity in body
weight loss induced by gastric bypass. Methods: A group
of 22 morbidly obese subjects, who were due to undergo a
gastric bypass, were submitted, before surgery, to a eu-
glycaemic–hyperinsulinaemic clamp, during which a con-
tinuous recording of the ECG was performed. The effect
of insulin on cardiac autonomic balance was evaluated by
performing power spectral analysis of heart rate variabil-
ity. The low-to-high frequency ratio was calculated before
and during the clamp and its modifications were expressed
as % delta low-to-high frequency ratio (%Δ L: H).
Results: Preoperative %Δ L: H showed a significant
(p=0.0009, r2=0.43), positive relationship to the reduction
of body weight, measured 1 year after surgery and ex-
pressed as % excess weight loss (% EWL). Preoperative
BMI was also significantly (p=0.0009, r2=0.43) negatively
related to the 12-month % EWL. In a multiple regression
analysis, %Δ L: H remained a significant (p=0.003), in-
dependent predictor of body weight loss, even when pre-
operative BMI or age, % fat mass, insulinaemia and
glucose disposal were taken into account. Conclusions/
interpretation: The best correction of excess body weight
was achieved by those obese subjects who had a preserved
capacity to shift their cardiac autonomic balance towards a
sympathetic prevalence in response to an euglycaemic–
hyperinsulinaemic clamp. Further studies are needed to
elucidate the mechanisms through which the autonomic
nervous system influences weight reduction.
Keywords Autonomic nervous system . Body weight
loss . Obesity . Roux-en-Y gastric bypass
Abbreviations % EWL: % excess weight loss . %Δ L: H:
% delta low-to-high frequency ratio . % FM: % fat mass .
LBM: lean body mass . LF: low frequency . HF: high
frequency . HRV: heart rate variability
Introduction
Bariatric surgery is the most efficient approach in the
treatment of morbid obesity [1]. In particular, Roux-en-Y
gastric bypass [2] has been demonstrated to yield sat-
isfactory results both in terms of extent and long-term
maintenance of weight loss [3, 4]. By this technique, an
average of excess weight loss (% EWL) of over 60% has
been repeatedly reported (review in [5]). Despite these ex-
cellent results, a large individual variability in outcome of
bariatric surgery is commonly observed, and, in a minority
of cases, patients do not obtain a 50% EWL, considered as
the inferior limit for a satisfactory result [6]. Thus, psy-
chological, anthropometric, metabolic and neurological
patient characteristics have been evaluated, in preoperative
conditions, in order to prove any predictive parameter. For
instance, it has been demonstrated that some psychological
traits, such as anxiety and excessive health concerns, are
linked to a less satisfactory result after gastric bypass [7],
whereas patients showing eating disorders are likely to
regain weight at long-term follow-up [8, 9]. Among the
anthropometric characteristics, initial BMI [10, 11] plays
an important role in surgically induced body weight loss.
Diabetes [12] has also been suggested as a predictor of a
lesser weight reduction following bariatric surgery.
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In a previous study [13], we investigated the sympatheti-
cally mediated vasoconstrictive response to a deep inspi-
ration, at the capillary level, in a group of obese subjects
undergoing a gastric bypass. We were able to demonstrate
that an elevated sympathetic reactivity was associated
significantly with a larger % EWL, 12 months after the
operation. This result is potentially useful in providing a
predictive parameter of the gastric bypass outcome. More
importantly, it also permitted a better understanding of the
complex physiopathology of the weight loss process. For
this reason, it seemed important to further characterise the
predictive role of autonomic reactivity in obese patients
undergoing a gastric bypass. Therefore, we investigated the
cardiac autonomic balance by performing spectral analysis
of the heart rate variability (HRV) before and during an
euglycaemic–hyperinsulinaemic clamp in a group of obese
subjects before the surgical intervention. Several studies
have investigated extensively the stimulatory effect of
insulin on sympathetic activity at the cardiac level [14–17].
Thus, it has been demonstrated that, in healthy subjects,
increased insulin plasma levels induce a shift of the au-
tonomic balance toward a sympathetic predominance [14,
15]. However, in insulin-resistant states, such as type 2
diabetes, hypertension or family history of diabetes, car-
diac autonomic responsiveness is altered [16, 17]. In obese
subjects, characterised by a high degree of insulin resis-
tance, the autonomic response to hyperinsulinaemia has
been reported to be either blunted [15] or even completely
abolished [14], suggesting a variable pattern of autonomic
responsiveness, among an obese population. The aim of the
present study was to investigate whether the variability of
the outcome of bariatric surgery could be linked to the
individual responsiveness of the autonomic nervous
system.
Subjects, materials and methods
A group of 22 morbidly obese women (age 38±2 years)
undergoing a Roux-en-Y gastric bypass participated in the
study. Among the patients, two were postmenopausal and
two were diabetic under oral treatment. Five patients had
impaired fasting glycaemia, i.e. between 6.0 and 6.9 mmol/
l [18]. Five subjects were under antihypertensive treatment;
no one was receiving beta-blocker agents. Patients were
informed about the methods and the design of the study,
which had been previously approved by the local Ethical
Committee, and gave their written consent. At the be-
ginning of the study, patients were in conditions of stable
body weight, i.e. their weight had not varied more than 5%
during the previous 6 months.
As previously indicated, patients were submitted to a
Roux-en-Y gastric bypass [19]. According to this surgical
procedure, a small stomach pouch (50-ml volume) is first
separated from the distal stomach; then, a Y-shaped section
of the small intestine is connected to the gastric pouch to
bypass the duodenum and a part of the jejunum. Finally,
this bypassed portion of the intestine is attached more dis-
tally to the small bowel.
Before surgery, patients were admitted to the hospital in
the morning, after a 10-h fasting period, and anthropomet-
ric measurements, i.e. body weight, height and body com-
position by bioelectrical impedance [20], waist and hip
measurements were performed. Excess weight (kg) was
calculated as: actual weight−normal weight. Normal body
weight of each patient, corresponding to a body mass index
of 25 kg/m2, was calculated as: 25×height2 (m).
After voiding, venous catheters and a Holter device were
placed for ECG recording; then patients remained quiet in a
supine position for a 30-min period, during which a first
basal ECG record was performed. A 120-min euglycaemic,
hyperinsulinaemic clamp test was then performed, as pre-
viously described [21]. Briefly, a priming dose of insulin
was administered during the first 10 min of the test, in order
to rapidly increase the circulating insulin levels. The total
amount of insulin administered during this 10-min period
was 0.8 U m−2 of body surface. An insulin infusion was
then maintained at the constant rate of 0.04 U m−2 min−1
until the end of the test. A 20% glucose solution was
infused at variables rates, in order to maintain glycaemia at
a value of 5 mmol/l. Blood samples were drawn every 5
min in order to measure glucose levels and to adjust the rate
of glucose infusion. During the last 30 min of the test, i.e.
when an insulin and glucose steady state was reached,
glucose uptake was measured and expressed in mg/kg of
lean body mass (LBM) per min. Plasma glucose was mea-
sured enzymatically [22] using a glucose analyser (Beck-
man Instruments, CA, Fullerton, USA); plasma insulin was
determined by radioimmunoassay, using commercial kits
(Linco Research, Inc., St. Charles, MI, USA).
During the steady-state period of the clamp, a second
ECG recording was performed.
HRV spectral measurements were performed on the two
30-min recording periods by a non-parametric method, the
fast Fourier transformation. The following spectral bands
were analysed: the low frequency (LF) and the high fre-
quency (HF) power, as well as the LF: HF ratio. The LF
component is modulated by both the sympathetic and
parasympathetic nervous systems and thus reflects a mix-
ture of both autonomic inputs. The HF component is gen-
erally defined as a marker of vagal modulation. The LF: HF
ratio reflects the global sympathovagal balance and is used
as a measure of this balance [23].
The modifications of the LF: HF ratio induced by eu-
glycaemic hyperinsulinaemia (i.e. during the clamp) were
calculated as %ΔL: H from the basal value (i.e. before the
clamp).
In order to reduce the effect of artefacts and of the
changes in total power, low frequency and high frequency
were also expressed in normalised units (NU). The nor-
malisation of LF and HF was obtained by subtracting from
total power the very low frequency component. This cal-
culation is useful when evaluating the effects of differ-
ent interventions in the same subject or when comparing
subjects with major differences in total power [24].
Body weight was remeasured 3 and 12 months after
surgery, and weight reduction was expressed as % excess
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weight loss, i.e. (excess weight−weight reduction)/excess
weight×100.
Weight loss was also expressed as % of initial weight
loss, i.e. weight reduction/initial body weight×100.
Simple and multiple regression analysis as well as
ANOVA for repeated measurements were used for the
statistical analysis. Results are indicated as means±SEM
and two-tailed p value for the significance.
Results
As indicated in Table 1, insulin plasma levels during the
clamp were increased from 1.2±0.1 to 5.1±0.4 ng/ml, while
glycaemia was maintained at a value of 5.2±0.1 mmol/l.
Glucose uptake was 3.4±0.4 mg/kg of LBM/min.
The mean value of the low-to-high frequency changed
from 2.05±0.45 in basal to 2.39±0.53 during the test. This
difference was not statistically significant (p=0.26), when
analysed by ANOVA for repeated measurements. As in-
dicated by Fig. 1, the L: H ratio showed a large individual
variability both before and during the clamp.
Among the parameters measured in preoperative condi-
tions, %ΔL: H showed a significant negative relationship
with age and % FM (p=0.04 and p=0.03, respectively). No
significant relationship was found between %ΔL: H and
glucose disposal (p=0.77).
After surgery, body weight sharply decreased between 0
and 3 months (rapid phase body weight loss), then it
continued to decrease more slowly between 3 and 12
months (slow phase body weight loss) (Table 2). The %
excess weight loss was 38.8±2.3 and 73.0±4.8%, respec-
tively, 3 and 12 months after surgery (Table 2): this means
that more than half of the global correction of excess body
weight was obtained during the rapid phase (0–3 months)
of body weight loss.
Weight reduction, expressed either as % EWL (Fig. 2a)
or as % reduction of initial weight (Fig. 2b), showed a
significant relationship with preoperative %ΔL: H (p=
0.0009, r2=0.43 and p=0.001, r2=0.42, respectively). Per-
Fig. 2 Relationship between the insulin-induced modifications of
the L: H ratio (%ΔL: H), measured in preoperative conditions vs
a the % excess weight loss (p=0.0009, r2=0.43, coef.=0.16) and vs
b % decrease of initial body weight (p=0.01, r2=0.42, coef.=−0.06)
Table 1 Metabolic and autonomic parameters measured before
and during the steady-state period of the clamp, in preoperative
conditions
Basal Clamp
Glycaemia (mmol/l) 5.6±0.3 5.2±0.1
Insulinaemia (ng/ml) 1.2±0.1 5.1±0.4
Glucose uptake (mg/kg of LBM/min) – 3.4±0.4
Low-to-high ratio 2.1±0.5 2.4±0.5
Fig. 1 Individual values of low-to-high frequency ratio measured
before and during the clamp, in preoperative conditions
Table 2 Anthropometric parameters measured in the study group
before and 3 and 12 months after gastric bypass
Before surgery 3 months 12 months
Body weight (kg) 119.7±3.2 100.0±3.1 81.30±3.3
BMI (kg/m2) 46.0±1.0 38.1±1.1 31.3±1.3
LBM (kg) 60.6±1.7 54.3±1.7 49.5±1.2
% FM 50.0±0.6 46.4±0.7 40.7±1.7
Waist-to-hip ratio 0.89±0.01 0.85±0.01 0.82±0.01
% Excess weight loss – 38.8±2.3 73.0±4.8
ANOVA for repeated measurements: all 3 and 12 months values are
significantly different from baseline for at least p=0.0002
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cent EWL also showed a significant (p=0.0009, r2=0.44),
negative relationship with preoperative BMI (Fig. 3).
When LF and HF were expressed in normalised units (NU),
%ΔL: H remained significantly related to % EWL (p=
0.003, r2=0.34).
When analysed by multiple regression analysis (Table 3),
%ΔL: H remained a significant (p=0.003) predictor of
% EWL, even when preoperative BMI was taken into ac-
count. Together, the %ΔL: H and preoperative BMI ex-
plained 61% of the variability in the correction of excess
body weight, obtained 1 year after surgery.
The extents of weight reduction obtained during the
rapid and the slow phase of body weight loss, respectively,
were evaluated separately in multiple regression analysis
(Table 3). This revealed that preoperative BMI signifi-
cantly (p=0.01), negatively influenced weight reduction
during the rapid phase, whereas %ΔL: H was significantly
(p=0.003), positively related to weight reduction occurring
during the slow phase of postoperative body weight loss.
When, in a multiple regression analysis, preoperative
age, % FM, insulinaemia and glucose disposal were taken
into account; %ΔL: H remained a significant (p=0.007),
independent predictor of % EWL (Table 4).
Preoperative glucose disposal, fasting glycaemia, in-
sulinaemia and weight/height did not show any predictive
role on % EWL.
Discussion
The main result of this study is the striking, positive
relationship between postoperative weight reduction and
preoperative insulin-stimulated shift of the cardiac auto-
nomic balance toward a sympathetic prevalence. In keep-
ing with our previous results [13], the present study further
underlines the involvement of the autonomic nervous
system in the outcome of surgically induced weight loss.
It is important to note that, in simple regression analysis,
the insulin-stimulated autonomic reactivity (i.e. %ΔL: H)
shows a predictive capacity as strong as the initial BMI,
which, up to now, was considered one of the best predictors
of weight loss after surgery [25]. In fact, when separately
analysed, %ΔL: H, as well as preoperative BMI, explained
over 40% of the weight reduction variability (Figs. 2, 3).
Autonomic reactivity exerts this predictive function inde-
pendently of the initial BMI. When taken together, these
two parameters were able to predict 60% of the variability
of the bariatric surgery outcome at 12 months. Moreover,
this predictive role still applies even when preoperative
age, % FM, insulinaemia and glucose disposal are taken
into account (Table 4).
The presence of a rapid and a slow phase of weight
reduction following gastric bypass has been well docu-
mented [26]: this profile is due mainly to the pattern of
energy intake, which is extremely low in the early post-
operative period and, then, progressively increases up to 1
year after surgery [13, 26, 27]. Our results clearly indicate
that, besides energy intake, other factors can influence
weight loss at different phases of the process. Thus, BMI
plays a major role during the early postoperative period,
whereas its influence becomes much weaker later on.
Dixon et al. [25] demonstrated that preoperative BMI is
strongly related to BMI measured 1 year, but not 2 years,
after surgery. This suggests that initial BMI does not in-
fluence weight maintenance or regain. Our results show
that, within the first postoperative year, initial BMI in-
fluences weight loss only during the rapid phase, i.e. when
energy intake is generally very low. Inversely, sympathetic
reactivity influences weight reduction positively during the
Fig. 3 Negative relationship between BMI (kg/m2), measured in
preoperative conditions and the % excess weight loss, measured 12
months after surgery (p=0.0009, r2=0.44, coef.=−3.24)
Table 4 Multiple regression analysis of % EWL measured 12
months after surgery vs several autonomic, anthropometric and
metabolic parameters measured in preoperative conditions
Dependent variable: % EWL
Independent variables Coefficient p
%ΔL: H 0.13 0.007
Age (years) 0.50 0.25
% FM −5.13 0.01
Insulinaemia (ng/ml) 3.87 0.55
Glucose disposal (mg/kg of LBM/min) −0.08 0.96
Table 3 Multiple regression analysis of extent of weight reduction,
evaluated either as total % excess weight loss 12 months after
surgery, or as % excess weight loss obtained respectively during the
fast (0–3 months) and the slow (3–12 months) phase of body weight
loss
Dependent variable Independent variables r2
% Excess weight loss %ΔL: H BMI













tardive, slow phase. It has been reported that a severe
caloric restriction elicits a remarkable reduction of the
sympathetic activity, probably aimed at reducing the en-
ergy deficit [28]. The drastic reduction of food intake
occurring soon after surgery could therefore ‘shut off’ the
sympathetic nervous system and, by consequence, deprive
it of any influence on weight loss during the early post-
operative period.
Although our previous [13] and current results clearly
establish that autonomic nervous system responsiveness
is predictive of weight loss, the underlying mechanisms
remain unknown.
Weight loss depends upon the extent of energy deficit,
i.e. the difference between energy intake and energy ex-
penditure. The autonomic nervous system could therefore
influence weight loss by acting either on energy expendi-
ture and/or on energy intake.
During severe caloric restriction, the overall sympathetic
activity is blunted [28]: this could negatively influence
energy expenditure. In turn, as we previously reported [29],
a decrease in energy expenditure could significantly ham-
per body weight loss.
Caloric restriction also enhances lipolysis by increasing
beta-adrenergic receptors in the adipose tissue [30, 31] and,
in normal body weight subjects, the norepinephrine spill-
over from the fat depots [32]. In obese subjects, a blunted
sympathetic activation in the adipose tissue district could
lead to defective lipolysis and, by consequence, to a smaller
weight reduction. In our study, the cardiac autonomic re-
sponsiveness could reflect that of the adipose tissue. Of
course, this hypothesis still has to be demonstrated to be
true. Interestingly, a recent paper [33] shows a significant
negative relationship between a sympathetic predominance
at the heart level and circulating adiponectin levels. Adi-
ponectin secretion is submitted to an inhibitory control by
the adrenergic system [34]. This result, therefore, suggests
that an increased sympathetic cardiac activity parallels a
sympathetic predominance in the adipose tissue.
In our experiments, euglycaemic hyperinsulinaemia did
not significantly affect the cardiac autonomic balance,
when evaluated in the whole group. This result is in agree-
ment with those previously reported in the literature, where
reduced [15] or absent [14] autonomic response to insulin
have been reported, in obese subjects. However, within the
study group, some subjects showed a preserved capacity to
shift towards a sympathetic predominance, in response to
insulin (Fig. 1). These same subjects were the ones who
achieved the best corrections of their overweight after
surgery. Autonomic activation was not significantly related
to insulin sensitivity. This result confirms those of Muscelli
et al. [35], who did not find any correlation between the
metabolic and the cardiologic parameters in a group of
obese patients. In our study, the autonomic responsiveness
was influenced by age and % FM, suggesting that the
control of autonomic function is influenced by numerous
factors. This multiple control could explain the lack of
relationship between the metabolic and the autonomic pa-
rameters. It could also account for the variability in the
autonomic responsiveness, even though this was found
only in obese females.
Nevertheless, this individual variability allowed us to
point out that a preserved autonomic flexibility is asso-
ciated with a larger correction of excess body weight.
It is generally agreed that the autonomic nervous system
works by sectors and, therefore, its activation or inhibition
in an organ/tissue does not necessarily occurs elsewhere.
For this reason, any possible correlation between cardiac
autonomic responsiveness and the one of other tissues/
organs needs to be demonstrated. However, cardiac au-
tonomic balance correlates with the autonomic nervous
activity in muscle [36] and with circulating adiponectin
[33], a hormone from the adipose tissue. On another hand,
its alteration in obese states needs no further demonstration
[14, 15]. All these results justify the utilisation of cardiac
autonomic activity when investigating the physiopathology
of energy balance.
In conclusion, our results demonstrate a strong pre-
dictive role of autonomic nervous system reactivity on the
extent of weight reduction. The elucidation of the mech-
anisms underlying this effect could provide us with im-
portant elements and improve our knowledge of the
physiopathology of obesity and body weight loss.
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